Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence

Published:2011-06 Issue:7 Volume:58 Page:1148-1156
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Marioni Gino,Staffieri Alberto,Giacomelli Luciano,Lionello Marco,Guzzardo Vincenza,Busnardo Alessandra,Blandamura Stella

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2011.03864.x/fullpdf

Reference26 articles.

1. The molecular target of rapamycin (mTOR) as a therapeutical target against cancer;Mita;Cancer Biol. Ther.,2003

2. Therapeutic targets: mTOR and related pathways;Dancey;Cancer Biol. Ther.,2006

3. Targeting mTOR in renal cell carcinoma;Hudes;Cancer,2009

4. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of Chinese patients with gastric cancer;Yu;Clin. Cancer Res.,2009

5. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment;Jiang;Drug Resist. Updat.,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of maspin tumor suppressor and mTOR in laryngeal carcinoma;American Journal of Otolaryngology;2020-01

2. mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis;Journal of Oral Pathology & Medicine;2015-12-12

3. A panel of biomarkers for predicting response to postoperative RT for laryngeal cancer?;American Journal of Otolaryngology;2014-11

4. The EGFR-mTOR pathway and laryngeal cancer angiogenesis;European Archives of Oto-Rhino-Laryngology;2013-09-25

5. A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk;PLoS ONE;2012-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3